Revamping the Digital Interface
Sitting Down With… David Wilbur, Former Director of Cytopathology and Clinical Imaging at Massachusetts General Hospital and current Chief Medical Scientist at Corista LLC, USA
Luke Turner |
Why has the US been slower to adopt digital pathology?
Although there is no question about the versatility and accuracy of digital pathology, there is a question surrounding its business case; most departments consider it a cost rather than a revenue-generating concept. European institutions have an advantage over those in the US because their health care systems incorporate digital pathology into their plans and fund these projects over a period of time. Here, we have to demonstrate that it can generate revenue, provide efficiency to save money, or improve patient safety before allocating the money and resources.
I believe that one of the main things holding back the adoption of digital pathology is the poor user interface between the pathologist and the viewing station – something that I have been trying to address over the last 15 years. As the product of over a century of development and fine-tuning, the microscope is exceedingly efficient and ergonomic for the user, and this is difficult to replicate in digital viewing systems. Inspired by the “Powerwall” at Leeds, which is a fantastic way to view digital slide images, I wanted to translate the way pathologists handle slides under the microscope into digital systems.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!